WASHINGTON — President Trump on Friday announced his intent to nominate Dr. Stephen Hahn to lead the Food and Drug Administration.
Hahn, an oncologist, is the chief medical executive at MD Anderson Cancer Center in Houston. While he is an accomplished physician and researcher, he has never worked in government — leaving his potential FDA agenda a mystery.
Health secretary Alex Azar also announced Friday that Dr. Brett Giroir, the assistant secretary for health, would helm the FDA on an acting basis while the Senate considers Hahn’s nomination. The appointment elevates a longtime Azar ally, giving the Trump administration’s socially conservative wing a powerful, if temporary, platform atop a semi-independent agency.
About the Author Reprints
Always thanks to you.
Is this the best candidate the administraion could come up with, after searching for months??
His previous leadership roles seem to imply questions about ethical & possible bigoted stances. National security in WWII was the justification for the Japanese-American incarceration in camps…
His MAIN QUALIFICATION would seem to be “large Republican political donor”!!
Using the word “qualified”, disqualifies us from truly commenting on this candidates. He is placing his credentials in harms way. Good luck young man?